In human ovarian cancer cells, miR-214 was found to induce cisplatin resistance primarily through targeting the PTEN/Akt pathway29, and in human lung cancer cell line HCC827, miR-214 was reported to regulate the acquired resistance to gefitinib via PTEN/AKT signaling pathway30. This evidence concerns the gene AKT1 and lung cancer.